Pages that link to "Q35553626"
Jump to navigation
Jump to search
The following pages link to Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen (Q35553626):
Displaying 35 items.
- Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation (Q26752528) (← links)
- Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target (Q33774610) (← links)
- Advances in graft-versus-host disease biology and therapy (Q34031916) (← links)
- CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response. (Q35207094) (← links)
- Anti–IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses (Q35553632) (← links)
- Targeting the interleukin-6/Jak/stat pathway in human malignancies (Q35925127) (← links)
- Advances in understanding the pathogenesis of graft-versus-host disease (Q35971439) (← links)
- JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor (Q35987345) (← links)
- IFNγR signaling mediates alloreactive T-cell trafficking and GVHD (Q36395621) (← links)
- Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia (Q36755491) (← links)
- Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. (Q36905580) (← links)
- Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future (Q36980277) (← links)
- STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity (Q37496786) (← links)
- Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease (Q37529686) (← links)
- Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade (Q37679267) (← links)
- Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation (Q38202009) (← links)
- Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis (Q38202155) (← links)
- Next generation treatment of acute graft-versus-host disease (Q38221028) (← links)
- T-cell plasticity in inflammatory skin diseases--the good, the bad, and the chameleons (Q38522520) (← links)
- NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2/STAT3 pathway (Q39032558) (← links)
- Identification of key genes implicated in the suppressive function of human FOXP3+CD25+CD4+ regulatory T cells through the analysis of time‑series data (Q47235478) (← links)
- Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. (Q48139357) (← links)
- Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use. (Q49222418) (← links)
- New and emerging therapies for acute and chronic graft versus host disease (Q49238507) (← links)
- The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia. (Q49384876) (← links)
- Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy (Q49679320) (← links)
- Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials (Q50115590) (← links)
- Targeting Aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function. (Q52927960) (← links)
- Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. (Q54186062) (← links)
- Immune Regulation in Hematopoietic Cell Transplantation (Q58415034) (← links)
- Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity (Q60046085) (← links)
- The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease (Q64257524) (← links)
- The role of allogeneic stem-cell transplant in myelofibrosis in the era of JAK inhibitors: a case-based review (Q90168426) (← links)
- Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease (Q91637969) (← links)
- Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019 (Q97646648) (← links)